Adma Biologics Inc [NASDAQ: ADMA] stock went on an upward path that rose over 2.65% on Thursday, amounting to a one-week price decrease of less than -0.32%. Over the last 12 months, ADMA stock rose by 85.63%. The one-year Adma Biologics Inc stock forecast points
Adma Biologics Inc [NASDAQ: ADMA] loss -2.06% on the last trading session, reaching $6.19 price per share at the time. The company report on March 11, 2024 at 7:00 AM that ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ &
Adma Biologics Inc [NASDAQ: ADMA] loss -3.83% on the last trading session, reaching $6.02 price per share at the time. The company report on March 11, 2024 at 7:00 AM that ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ &
Adma Biologics Inc [NASDAQ: ADMA] jumped around 0.32 points on Wednesday, while shares priced at $6.12 at the close of the session, up 5.52%. The company report on March 5, 2024 at 7:00 AM that ADMA Biologics to Participate in the Raymond James Institutional Investor
Adma Biologics Inc [NASDAQ: ADMA] loss -0.37% on the last trading session, reaching $5.36 price per share at the time. The company report on February 28, 2024 at 4:10 PM that ADMA Biologics Announces CFO Transition. Executive Search Initiated for CFO Replacement. If compared to
© 2024, Powered by Smart TechOne
